| Literature DB >> 34203804 |
Silvia Lomartire1, João Carlos Marques1, Ana M M Gonçalves1,2.
Abstract
Currently, seaweeds are gaining major attention due to the benefits they give to our health. Recent studies demonstrate the high nutritional value of seaweeds and the powerful properties that seaweeds' bioactive compounds provide. Species of class Phaeophyceae, phylum Rhodophyta and Chlorophyta possess unique compounds with several properties that are potential allies of our health, which make them valuable compounds to be involved in biotechnological applications. In this review, the health benefits given by consumption of seaweeds as whole food or by assumption of bioactive compounds trough natural drugs are highlighted. The use of seaweeds in agriculture is also highlighted, as they assure soils and crops free from chemicals; thus, it is advantageous for our health. The addition of seaweed extracts in food, nutraceutical, pharmaceutical and industrial companies will enhance the production and consumption/usage of seaweed-based products. Therefore, there is the need to implement the research on seaweeds, with the aim to identify more bioactive compounds, which may assure benefits to human and animal health.Entities:
Keywords: bioactive compounds; human health; nutraceutical application; pharmaceutical application; seaweeds
Mesh:
Substances:
Year: 2021 PMID: 34203804 PMCID: PMC8232781 DOI: 10.3390/md19060341
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Biological compounds isolated from Phaeophyceae.
| Type of Algae | Isolated Compounds | Type of Compound | Reference |
|---|---|---|---|
| Phaeophyceae | Laminaran | Polysaccharide of glucose | [ |
| Fucoidan | Sulphated polysaccharide | [ | |
| Alginic acid | Polysaccharide | [ | |
| Phlorotannin | Polyphenolic compound | [ | |
| Fucoxanthin | Pigment | [ |
Figure 1Chemical structure of fucoxanthin.
Figure 2Chemical structure of sulphate polysaccharide (SP) fucoidan.
Figure 3Chemical structure of alginic acid.
Figure 4Chemical structure of laminaran.
Figure 5Chemical structure of eckol (A) and phlorofucofuroeckol A (B), phlorotannins isolated from Ecklonia cava.
Biological compounds isolated from Rhodophyta.
| Type of Algae | Isolated Compounds | Type of Compound | Reference |
|---|---|---|---|
| Rhodophyta | Carrageenans | Sulphated polysaccharides | [ |
| Sesquiterpenes | Mixture of polysaccharide agarose and small molecules | [ | |
| Diterpenes | Terpenes | [ | |
| Triterpenes | Terpenes | [ |
Figure 6Chemical structure of κ-carrageenan.
Figure 7Chemical structure of agarose polymer.
Biological compounds isolated from Chlorophyta.
| Type of Algae | Isolated Compounds | Type of Compound | Reference |
|---|---|---|---|
| Chlorophyta | Ulvan | Sulphated polysaccharides | [ |
| Palmitic acid | Saturated fatty acid | [ | |
| Linoleic acid | Polyunsaturated fatty acid | [ | |
| Chlorophylls (a and b) | Pigments | [ | |
| Carotenoids (β-carotene and xanthophylls) | Pigments | [ |
Figure 8Chemical structure of ulvan.
Main compounds of seaweeds involved in biotechnological applications.
| Seaweed | Main Bioactive Compound | Property | Biotechnological Application | Reference |
|---|---|---|---|---|
| Phaeaophyceae | ||||
|
| Alginate | Biodegradability, biocompatibility, non-toxic behaviour | Cosmetics, pharmaceutical and food industries as stabilizers | [ |
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| Alginate | Biodegradability, biocompatibility, non-toxic behaviour | Cosmetics as a thickening agent | [ |
| Phlorotannins | Antioxidant activity | Cosmetics for preventing skin aging | [ | |
|
| Phlorotannins | Anticancer, antioxidant, anti-inflammatory, antiviral activities and antihypertensive effects. | Pharmaceutical and nutraceutical industries | [ |
|
| Phlorotannins | Antiallergic effects | Pharmaceutical industry | [ |
|
| Phlorotannins | Antidiabetic, antioxidant, antitumor, anti-inflammatory, and anticancer activities | Pharmaceutical and medical industries | [ |
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| Phlorotannins | Anti-inflammatory and antioxidant properties | Cosmetics, to produce make-up and sunscreens | [ |
|
| Fucoidans | Anticoagulant activity | Potential substitute to heparin | [ |
|
| ||||
| Rhodophyta | ||||
|
| λ-carrageenan and κ-carrageenan | High viscosity in drinks; antitumoral property | Food industry (production of drinks, e.g., milk and chocolate) and pharmaceutical industry | [ |
|
| ||||
|
| ||||
|
| κ-carrageenan | Antitumoral activity against human nasopharynx carcinoma, human gastric carcinoma, and cervical cancer cell lines | Pharmaceutical industry | [ |
|
| κ-carrageenan and agar | Antioxidant properties | Cosmetics and nutraceutical industry | [ |
|
| Agar | Antidiabetic, antioxidant, antimicrobial, anticoagulant, anti-inflammatory, and antitumoral activities; hypoglycaemic activity | Pharmaceutical industry | [ |
|
| Halogenated metabolites | Antitumoral activity | Pharmaceutical industry | [ |
|
| Diterpene and sesquiterpene | Actions against different cancer cell lines (KB, HepG2 and MCF-7) | Pharmaceutical industry | [ |
| Griffith (Protein) | Antiviral activity against MERS-CoV-2 virus and SARS-CoV-2 glycoprotein | Pharmaceutical industry | [ | |
| Chlorophyta | ||||
|
| Phenolic compounds and flavonoids | Antioxidant, scavenging, anti-proliferative activities of cancer line cells | Pharmaceutical and nutraceutical industries | [ |
|
| Ulvan | Antioxidant activity, antimicrobial and photocatalytic activities | Food industry (the whole body is used as salad) and industrial industry (production of biogas and biodiesel) | [ |
|
| Ulvan | Antigenotoxic activity in human lymphocytes; hypoglycaemic effect in vivo experiment | Pharmaceutical industry | [ |
|
| Ulvan | Antioxidant and good mechanical properties; antiviral property | Industrial industry to develop bioplastics; pharmaceutical industry | [ |
Preclinical studies on cell lines performed with seaweed bioactive compounds.
| Preclinical Trial | Cell Lines Surveyed | Dosage (µg/mL) | Effect | Reference |
|---|---|---|---|---|
| Antitumoral activity of carregaagenans and oligosaccharide fractions of carregaagenans from | Human nasopharyngeal carcinoma (KB), human gastric carcinoma (BGC) and human hela carcinoma (Hela) | 500, 250, 125 | The results of bioassay showed that the fraction F1 exhibits relatively higher antitumor activity against three cancer cells in vitro than polysaccharides | [ |
| Antitumoral activity of ethanol:water extracts and ethanol:chloroform extracts of | Jurkat cancer cells | 25–1000 | The number of the viable cells is decreased with ethanol:chloroform extract with IC50 value of 57.77 µg/mL is (more cytotoxic than the ethanol:water extract with IC50 value of 121.642 µg/mL) | [ |
| Antitumoral activity of three sesquiterpenes (12-hydroxy isolaurene 8,11-dihydro-12-hydroxy isolaurene | Ehrlich cells (Ehrlich ascites Carcinoma, EAC) | 25, 50, 100 | Isolauraldehyde proved to have the highest cytotoxic activity (83.1%) followed by compound 2 (79.9%) | [ |
| Antitumoral activity of ethanolic extract of | Ehrlich ascites tumour (EAT) cells from mice | 0–100 | EAT cells viability was close to 65% At 50 μg/mL dose and the maximum decrease of 15% was observed at 100 μg/mL | [ |
| Antigenotoxicity activity of | 10, 20, 40 | Genotoxic activity in human lymphocyte cell culture was not high, while | [ | |
| Activation of LXRα or LXRβ (nuclear receptor) from polysaccharide extracts of | Human microglia cells (CHME3) from University Paris-Sud, France and in vivo from mice used as model of survey for AD | 1, 3, 5 | In vitro CHME3 cells showed a significantly activation of LXRβ but not LXRα with dose of 5 µg/mL. In vivo test showed after ten weeks LXR activation in the central nervous system, evidenced by a cerebral induction of LXR response genes | [ |
| Protection against Aβ- induced neurotoxicity in PC12 cells trough isolated phlorotannins from | Rat pheochromocytoma cells (PC12 cells) obtained from American Type Culture Collection (ATCC) | 2.5, 5, 10, 20 | 7-phloroeckol and phlorofucofuroeckol A have been shown to be potent neuroprotective agents | [ |
| Protection against hydrogen peroxide (H2O2)-induced damage trough sulfated polysaccharides from | Monkey kidney fibroblasts (Vero cells) | 12.5, 25, 50 | In vivo and in vitro tests showed the potential of polysaccharides extracted as neurorepair in animals | [ |
Pharmaceutical effects of seaweed bioactive compounds.
| Seaweed | Compound Extracted | Cell Lines/Animals Surveyed | Route of Administration | Dosage (µg/mL) | Effect | Reference |
|---|---|---|---|---|---|---|
| Sulphated fucan | Human plasma | The lyophilized crude polysaccharide was dissolved in human plasma | 10, 30, 50 | In vitro anticoagulant activity | [ | |
| Fucoidans | Human plasma | Intravenous Injection | 125, 250, 500, 1000 | In vitro and in vivo anticoagulant activity | [ | |
| Phlorotannins, grasshopper ketone, fucoidan and polysaccharides | Mice | Oral administration | Based on weight of mice | Antioxidant, anticancer, anti-inflammatory, antibacterial, and anticoagulant activities | [ | |
| Phenolic, Flavonoid and Alkaloid compounds | Bovine serum albumin (protein) | The extracts were tested on the protein | 20, 40, 60, 80, 100, 120 | Hypoglycaemic activity | [ | |
| Ethanolic extract | Twenty-four male Wistar rats | Oral administration | 500 mL of water with extracts in 2% wt/vol as drinking water for exposed groups per each day (from 3 to 30 days). | In vivo anti-hyperglycaemic, antioxidative and genotoxic/antigenotoxic activities | [ | |
| Griffithsin (protein) | MERS-CoV and SARS-CoV glycoproteins | The extracts were tested on the proteins | 0.125, 0.25, 0.5, 1, 2 | Antiviral activity against MERS-CoV virus and SARS-CoV glycoprotein | [ | |
| polysaccharides | SARS-CoV-2 S-protein | The extracts were tested on the protein | 50–500 | In vitro inhibition to SARS-CoV-2 | [ |